Code
3F016109
Duration
01 October 2009 → 31 August 2012
Funding
Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
Promotor
Fellow
Research disciplines
-
Medical and health sciences
- Gastro-enterology and hepatology
- Morphological sciences
- Oncology
- Gastro-enterology and hepatology
- Morphological sciences
- Oncology
- Gastro-enterology and hepatology
- Morphological sciences
- Oncology
Keywords
placental growth factor
angiogenesis
hepatocellular carcinoma
Project description
Inhibiting angiogenesis deprives the tumor from its nutrient supply, slowing down tumor growth and meastasis. PlGF is only involved in the pathogenic angiogenesis, therefore blokking PlGF does not influence healthy organs. The goal of our study is assessing PlGF in the pathogenesis of HCC and testing angiogenesis-inhibition through PlGF-antibodies as a valable therapy against HCC.